HOME >> BIOLOGY >> NEWS
JCI table of contents, March 23, 2006

EDITOR'S PICK

Clarifying controversy in multiple sclerosis

Multiple sclerosis (MS) is a crippling autoimmune disease of the central nervous system (CNS) in which the protective nerve cell coating called myelin is damaged. Although uncontrolled CNS inflammation by immune cells called microglia (MG) and production of the protein TNF-alpha are considered important causes of demyelination and loss of nerve (neuron) function in MS, there is evidence to suggest that a controlled inflammatory response may actually restore damaged myelin and nerve function. Now, in a study appearing online on March 23 in advance of print publication in the April issue of the Journal of Clinical Investigation, researcher Michal Schwartz and colleagues at the Weizmann Institute of Science in Israel help clarify the controversy by reporting that it is the mechanism by which the MGs are activated that determines whether they are destructive or protective. Using both mouse and rat animal models of MS, the authors show that production by immune cells known as helper T cells of small amounts of a proinflammatory protein called IFN-gamma or production of an anti-inflammatory protein IL-4 could stimulate MGs to support nerve cell survival. In contrast, the researchers show that MGs fail to protect neurons when they are exposed to high doses of IFN-gamma, because high levels of IFN-gamma stimulate the MGs to produce TNF-alpha. The results demonstrate that the helper T cells can have direct control over MG action, stimulating them to either support or destroy nerve cell function through production of IL-4, and suggest that stimulation of MGs with IL-4 may help in MS clinical recovery.

TITLE: Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis

AUTHOR CONTACT:
Michal Schwartz
Weizmann Institute of Science, Rehovot, Israel
Phone: 972-8-93-42467; Fax: 972-8-93-46
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
23-Mar-2006


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2019)... Denmark and RALEIGH, N.C. (PRWEB) , ... January ... ... in micro acoustic and micro mechanical technologies and solutions for hearing instruments and ... technology, today announced BiometRIC, the first ever hearing aid receiver in canal with ...
(Date:1/4/2019)... ... January 03, 2019 , ... ... culture models into their drug discovery research workflows with biology ranging from single ... vivo relevancy of in vitro studies, they create several challenges that need to ...
(Date:12/22/2018)... , ... December 21, 2018 , ... ... sponsored and hosted the Boston Healthcare Drinks event featuring Helen Chen, Greater China ... from China.” , The discussion was moderated by patent attorney David J. ...
Breaking Biology News(10 mins):
(Date:1/15/2019)... (PRWEB) , ... January 15, 2019 , ... With the U.S. Congress designating January as ... transmitted disease (STD) testing service, today announces tips to help reduce the risk of Cervical ... Human Papillomavirus (HPV). Genital HPV is the #1 most common STD and an ...
(Date:1/10/2019)... ... January 08, 2019 , ... Rascal was adopted from a local shelter when he was ... mixed breed.” Unfortunately, just six weeks after he was adopted, he tore his right ... to form in the joint after such a traumatic injury. , Sure enough, when Rascal ...
(Date:1/8/2019)... ... January 07, 2019 , ... ... members into Noninvasix. This represents the second investment AngelMD has made into Noninvasix ... morbidity, Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure ...
(Date:1/4/2019)... ... January 04, 2019 , ... Triangle Insights ... to the firm. Ted will be joining the firm as a partner. ... consulting services to the pharmaceutical industry. At Triangle Insights, Ted will apply his ...
Breaking Biology Technology:
Cached News: